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Case Report 
Primary Leiomyosarcoma of the Ureter
Chen Lv, Ning Chen,1 Xuan Zhu, Xuanzhi Zhang and Zhaohui Zhong, Departments of Urology and 
1Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Leiomyosarcoma is a rarely seen neoplasm of the ureter, with less than 20 cases being reported in the 
literature to date. It is important to distinguish leiomyosarcoma from rhabdomyosarcoma, with the aid
of immunohistochemical markers. We report the clinical features, histology, imaging and treatment of
ureteral leiomyosarcoma in a female patient. [Asian J Surg 2008;31(4):191–4]
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Introduction
Malignant neoplasms of the ureter are typically transi-
tional cell carcinoma with squamous cell carcinoma, and
adenocarcinoma comprises nearly all of the remaining
cases. Leiomyosarcoma is a rarely seen neoplasm of the
ureter with fewer than 20 cases being reported in the litera-
ture to date.1,2 It is important to distinguish leiomyosarcoma
from rhabdomyosarcoma, with the aid of immunohis-
tochemical markers. Here we report a case of ureteral
leiomyosarcoma in a female patient.3
Case report
A 47-year-old woman presented to our hospital with a
dull pain in the right flank, which had persisted for 
4 months. She did not complain of any history of urolog-
ical calculus and no gross haematuria was noted.
Ultrasonography identified right moderate hydro-
nephrosis with dilation of the proximal ureter. Computed
tomography (CT) showed the presence of a soft mass (3 ×
3 cm), which extended from the right ureters, with dila-
tion of the proximal ureter and renal pelvis (Figure 1). The
affected ureteral wall possessed surrounding incrassation,
which formed a 3.5×3.5-cm soft-tissue mass. Furthermore,
the lumen of the affected ureter appeared to be irregular
in shape. After injection of contrast medium, the mass
was greatly enhanced, with a clear portion in the nearby
tissues. The distance of the mass from the renal pelvis was
about 8 cm. Further examination identified microscopic
haematuria, and ureteroscopy revealed a soft mass that
obstructed the lumen of the ureter. A biopsy of the mass
was performed, and pathological examination identified
characteristics of leiomyosarcoma.
The patient was surgically treated by right nephro-
ureterectomy, with retroperitoneal lymphadenectomy.
The soft mass was 3.5 cm in diameter, with proximal ureter
dilation (Figure 2). Pathological examination showed that
the cancer was composed of fascicles of interlacing, moder-
ately large, spindle-shaped cells, with abundant eosinophilic
cytoplasm. Immunohistochemistry showed strong stain-
ing for smooth muscle actin (SMA) (Figures 3 and 4). A
diagnosis of leiomyosarcoma of the right ureter was made,
and three retroperitoneal lymph nodes were dissected and
confirmed as negative for tumour by pathological exami-
nation. The cutting margin of the ureter near the bladder
was negative and the kidney was intact. No adjuvant
chemotherapy was given after surgery. The patient’s con-
valescence was uneventful at 6 months after surgery.
However, the patient presented again with emaciation
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Figure 1. Computed tomography of leiomyosarcoma of the ureter. (A) A soft mass (3 × 3 cm) extending from the right ureter. The
affected ureteral wall possessed surrounding incrassation. The mass was substantially enhanced with injection of contrast medium.
(B) Dilation of the proximal ureter and renal pelvis.
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Figure 2. Gross appearance of leiomyosarcoma of the ureter. (A, B) Grossly, the appearance was a solid, greyish, lobulated mass
with a trabeculated surface. The affected ureteral wall possessed surrounding incrassation, and formed a 3.5 × 3.5-cm soft-tissue
mass. The lumen of the affected ureter appeared to be irregular in shape. The collecting system of the affected kidney had moderate
dilation.
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Figure 3. Histological appearance of leiomyosarcoma of the ureter. (A, B) Typical architecture of leiomyosarcoma with fascicles of
spindle cells arranged at right angles. Cells were non-tapered and may have blunt-ended nuclei; occasional paranuclear vacuoles
were evident. Focal nuclear pleomorphism was seen. Tumours were mitotically active, and myxoid change incorporated nodules of
the tumour (haematoxylin & eosin, 100×). (B) The tumour had no capsule and the cells encroached upon peripheral normal smooth
muscle tissue (haematoxylin & eosin, 100×).
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and a dull pain in the same position. CT showed involve-
ment of the retroperitoneal lymph nodes, and consequent
therapy was not carried out due to the patient’s personal
wishes.
Discussion
Leiomyosarcoma is a rare soft-tissue tumour that accounts
for 10–20% of soft-tissue sarcoma, is generally seen in
middle-aged patients, and afflicts women more frequently
than men.4 Its usual locations, in order of frequency 
are: retroperitoneal, intra-abdominal, cutaneous and 
subcutaneous.
Leiomyosarcoma is a highly malignant tumour with
an extremely poor prognosis. The 5-year overall survival
rate in patients with soft-tissue sarcoma of all stages
remains poor, at only 50–60%, and 5-year disease-free sur-
vival is rare.3,5,6 In one study, the 5-year survival of 705
patients with leiomyosarcoma from 22 series was 27.8%.7
A literature review has revealed only 17 cases of primary
leiomyosarcoma of the ureter, and metastasis is reported
to have occurred in eight patients, with four having died
from the disease.8 In our case report, the recurrence of
node-negative leiomyosarcoma at 6 months after surgical
excision is unusual.
An important aspect of the management of leiomyo-
sarcoma is to differentiate the lesion from rhabdomyosar-
coma and other spindle-cell neoplasms. This is especially
difficult with poorly differentiated high-grade lesions. On
immunohistochemistry, leiomyosarcoma is negative for
epithelial markers (cytokeratins and epithelial membrane
antigens). Positivity for desmin and SMA shows the smooth
muscle origin of the tumour and gives a definitive diag-
nosis. Negative myoglobin, cytokeratin and S-100 help to
rule out rhabdomyosarcoma, sarcomatoid carcinoma,
and melanoma, respectively.9,10
Leiomyosarcoma shows nodular aggregates and densely
packed, interlacing bundles of smooth-muscle cells in the
centre. At the margin, strands of smooth muscle cells
extend between collagen bundles. Areas of lesser differ-
entiation are present in all tumours to varying degrees,
including irregularly shaped, anaplastic nuclei and atypical
giant cells with bizarre nuclei. A high mitotic rate remains
the main criterion for leiomyosarcoma, and other histo-
pathological features of the tumour include atypical
smooth-muscle cells with peripheral extension into the
surrounding tissue, pleomorphism, giant cells, and necrosis
of the tumour and peripheral tissue.
Only some rhabdomyosarcomas contain cells that are
recognizable as rhabdomyoblasts, by virtue of their cyto-
plasm exhibiting cross-striation, which is best revealed 
by phosphotungstic acid-haematoxylin staining. Round
cells of the embryonal variant tend to have cytoplasmic
rims that are stained red by trichrome. The botryoid type
is a variant of the embryonal type and is found mainly 
in mucosa-lined hollow organs. Cells with elongated
eosinophilic cytoplasm may be suggestive but not neces-
sarily diagnostic of rhabdomyosarcoma, and may be
found in the pleomorphic type. A sclerosing variant has
cords of small, round malignant cells embedded in a
densely hyalinized matrix that has a chondroid and
osteoid appearance.
Immunohistochemical staining of deparaffinized sec-
tions shows expression of desmin and muscle-specific
actin in the great majority of leiomyosarcomas. Anti-desmin
staining is found in 47–85% of superficial leiomyosarcomas,
and is less common in higher-grade tumours. Immuno-
histochemical studies of deparaffinized tissue may show
rhabdomyosarcoma cells to be positive for vimentin, which
indicates a mesenchymal phenotype. More differentiated
cells may be positive for desmin and myoglobin, which is
indicative of muscular differentiation.
Wide local excision is considered the treatment of
choice with radiation and chemotherapy being offered to
patients with positive margins or nodes, or those with
bulky disease.1,2 Radiotherapy can be considered for larger
tumours and/or positive margins, if anatomically feasible.
Adjuvant chemotherapy has not been proven to be effec-
tive and remains investigational. Treatment for metastatic
Figure 4. Actin protein, a smooth muscle marker, was strongly
expressed in tumour cells (AEC stain, 100×).
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disease is palliative. Active agents include doxorubicin,
ifosfamide, gemcitabine and docetaxel.
Since there is no mode of definitive treatment for this
rare disease, one must extrapolate from modes of treat-
ment of leiomyosarcoma of the ureter and epithelial
tumours of the ureter. In our case, radical surgical exci-
sion of the kidney, surrounding tissues, lymph nodes and
ureter was accomplished.
We conclude that, although leiomyosarcoma is rarely
seen, it should be listed in the differential diagnosis of
ureter tumours.
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